UB Paderborn / Katalog / Suche / in CDI

Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis

Cell death & disease, 2012-03, Vol.3 (3), p.e277-e277

2012

Volltextzugriff (PDF)

The shadow of death on the MET tyrosine kinase receptor

Cell death and differentiation, 2008-03, Vol.15 (3), p.427-434

2008

Volltextzugriff (PDF)

Caspases shutdown nonsense-mediated mRNA decay during apoptosis

Cell death and differentiation, 2015-11, Vol.22 (11), p.1754-1763

2015

Volltextzugriff (PDF)

Implication des mutations de MET dans la résistance aux inhibiteurs de l’EGFR des cancers bronchiques non à petites cellules

Revue des maladies respiratoires, 2021-06, Vol.38 (6), p.579-580

2021

Volltextzugriff (PDF)

Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity

Oncogene, 2009-06, Vol.28 (22), p.2185-2195

2009

Volltextzugriff (PDF)

Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations

Annals of oncology, 2018-10, Vol.29, p.viii541-viii541

2018

Volltextzugriff (PDF)

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

Cell death & disease, 2013-10, Vol.4 (10), p.e871-e871

2013

Volltextzugriff (PDF)

Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor

Cell death and differentiation, 2007-04, Vol.14 (4), p.752-764

2007

Volltextzugriff (PDF)

Les mutations des sites d’épissage de l’exon 14 de MET. Une nouvelle opportunité thérapeutique dans le cancer du poumon

Revue des maladies respiratoires, 2018-10, Vol.35 (8), p.796-812

2018

Volltextzugriff (PDF)

MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer

Revue des maladies respiratoires, 2018-10, Vol.35 (8), p.796

2018

Volltextzugriff (PDF)

Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

Molecular and Cellular Biology, 2004-12, Vol.24 (23), p.10328-10339

2004

Volltextzugriff (PDF)

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation

Oncogene, 2007-01, Vol.26 (3), p.395-406

2007

Volltextzugriff (PDF)

Necrosis- and apoptosis-related Met cleavages have divergent functional consequences

Cell death & disease, 2015-05, Vol.6 (5), p.e1769-e1769

2015

Volltextzugriff (PDF)

Étude des réponses biologiques induites par le récepteur Met lors de la résistance aux inhibiteurs d’EGFR dans les adénocarcinomes pulmonaires

Revue des maladies respiratoires, 2015-03, Vol.32 (3), p.307-307

2015

Volltextzugriff (PDF)

Étude de l’impact des mutations juxtamembranaires de Met répertoriées dans le cancer pulmonaire sur ses clivages protéolytiques

Revue des maladies respiratoires, 2014-01, Vol.31, p.A27-A28

2014

Volltextzugriff (PDF)

Thirty years of research on met receptor to move a biomarker from bench to bedside

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6737-6744

2014

Volltextzugriff (PDF)

The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen

Thrombosis and haemostasis, 2001-07, Vol.86 (1), p.276

2001

Volltextzugriff (PDF)

Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells

Molecular biology of the cell, 2000-11, Vol.11 (11), p.3751-3763

2000

Volltextzugriff (PDF)

1493PClinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S851-S851

2019

Volltextzugriff (PDF)

357 Characterization of the transcriptional networks involving PEA3 transcription factors during mammary morphogenesis and tumourigenesis

European journal of cancer supplements, 2010, Vol.8 (5), p.91-91

2010

Volltextzugriff (PDF)

Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni

The Journal of biological chemistry, 2004-09, Vol.279 (36), p.37407-37414

2004

Volltextzugriff (PDF)

Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21561-21566

2002

Volltextzugriff (PDF)

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway

Oncogene, 2002-04, Vol.21 (15), p.2309-2319

2002

Volltextzugriff (PDF)

Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI

Blood, 2002-06, Vol.99 (11), p.4219-4221

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis

The shadow of death on the MET tyrosine kinase receptor

Caspases shutdown nonsense-mediated mRNA decay during apoptosis

Implication des mutations de MET dans la résistance aux inhibiteurs de l’EGFR des cancers bronchiques non à petites cellules

Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity

Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor

Les mutations des sites d’épissage de l’exon 14 de MET. Une nouvelle opportunité thérapeutique dans le cancer du poumon

MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer

Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation

Necrosis- and apoptosis-related Met cleavages have divergent functional consequences

Étude des réponses biologiques induites par le récepteur Met lors de la résistance aux inhibiteurs d’EGFR dans les adénocarcinomes pulmonaires

Étude de l’impact des mutations juxtamembranaires de Met répertoriées dans le cancer pulmonaire sur ses clivages protéolytiques

Thirty years of research on met receptor to move a biomarker from bench to bedside

The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen

Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells

1493PClinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations

P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study

357 Characterization of the transcriptional networks involving PEA3 transcription factors during mammary morphogenesis and tumourigenesis

Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni

Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway

Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI

Suchergebnisse filtern